Aton Ra Partners Neurocrine Biosciences Inc Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Aton Ra Partners holds 5,002 shares of NBIX stock, worth $625,250. This represents 1.31% of its overall portfolio holdings.

Number of Shares

5,002

Previous 5,562 10.07%

Holding current value

$625,250

Previous $625,000 5.44%

% of portfolio

1.31%

Previous 1.31%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$106.07 - $132.76 $59,399 - $74,345	-560 Reduced 10.07%	5,002 $659,000
Q3 2023 Oct 25, 2023	SELL	$94.02 - $117.1 $121,567 - $151,410	-1,293 Reduced 18.86%	5,562 $625,000
Q2 2023 Jul 18, 2023	SELL	$89.53 - $104.87 $40,825 - $47,820	-456 Reduced 6.24%	6,855 $646,000
Q1 2023 May 05, 2023	SELL	$94.11 - $123.02 $64,747 - $84,637	-688 Reduced 8.6%	7,311 $740,000
Q4 2022 Feb 02, 2023	SELL	$106.72 - $127.06 $340,116 - $404,940	-3,187 Reduced 28.49%	7,999 $955,000
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $23,467 - $27,491	-255 Reduced 2.23%	11,186 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $162,796 - $214,950	-2,148 Reduced 15.81%	11,441 $1.12 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $49,266 - $64,470	680 Added 5.27%	13,589 $1.27 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $86,898 - $115,886	1,091 Added 9.23%	12,909 $1.1 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $78,854 - $90,612	915 Added 8.39%	11,818 $1.13 Million
Q2 2021 Aug 12, 2021	SELL	$89.43 - $102.27 $1.57 Million - $1.79 Million	-17,510 Reduced 61.63%	10,903 $1.06 Million
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $261,484 - $356,528	2,986 Added 11.74%	28,413 $2.76 Million
Q4 2020 Feb 19, 2021	BUY	$86.91 - $108.33 $2.21 Million - $2.75 Million	25,427 New	25,427 $2.44 Million

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account